Inhibiting Human and <i>Leishmania</i> Arginases Using <i>Cannabis sativa</i> as a Potential Therapy for Cutaneous Leishmaniasis: A Molecular Docking Study
Cutaneous leishmaniasis (CL), a vector-borne parasitic disease caused by the <i>Leishmania</i> protozoan, is a serious public health problem in Morocco. The treatment of this disease is still based on pentavalent antimonials as the primary therapy, but these have associated side effects....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Tropical Medicine and Infectious Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2414-6366/7/12/400 |